SEOM clinical guidelines for the management of adult soft tissue sarcomas

Soft tissue sarcomas are uncommon tumors of mesenchimal cell origin. Criteria for suspicion is a soft tissue mass that is increasing in size, and has a size greater than 5 cm or is located under the deep fascia. Diagnosis and management of these patients should preferably be performed by a specialist multidisciplinary team in a referral center. Assessment of a patient with a suspect of sarcoma should include magnetic resonance and biopsy performed prior to surgery. Primary local therapy for patients with localized sarcoma is based on wide surgical resection with a tumor-free tissue margin, in association in most cases with radiotherapy. Adjuvant chemotherapy constitutes an option that could be considered in high-risk sarcomas of the extremities. When metastasis are present, surgery of pulmonary lesions, in some selected patients, and chemotherapy are current available options (AU)

Complexes of Pd(II) and Pt(II) with 9-aminoacridine: reactions with DNA and study of their antiproliferative activity.

Four new metal complexes {M = Pd(II) or Pt(II)} containing the ligand 9-aminoacridine (9AA) were prepared. The compounds were characterized by FT-IR and (1)H, (13)C, and (195)Pt NMR spectroscopies. Crystal structure of the palladium complex of formulae [Pd(9AA)(mu-Cl)](2) . 2DMF was determined by X-ray diffraction. Two 9-acridine molecules in the imine form bind symmetrically to the metal ions in a bidentate fashion through the imine nitrogen atom and the C(1) atom of the aminoacridine closing a new five-membered ring. By reaction with phosphine or pyridine, the Cl bridges broke and compounds with general formulae [Pd(9AA)Cl(L)] (where L = PPh(3) or py) were formed. A mononuclear complex of platinum of formulae [Pt(9AA)Cl(DMSO)] was also obtained by direct reaction of 9-aminoacridine and the complex [PtCl(2)(DMSO(2)]. The capacity of the compounds to modify the secondary and tertiary structures of DNA was evaluated by means of circular dichroism and electrophoretic mobility. Both palladium and platinum compounds proved active in the modification of both the secondary and tertiary DNA structures. AFM images showed noticeable modifications of the morphology of the plasmid pBR322 DNA by the compounds probably due to the intercalation of the complexes between base pairs of the DNA molecule. Finally, the palladium complex was tested for antiproliferative activity against three different human tumor cell lines. The results suggest that the palladium complex of formula [Pd(9AA)(mu-Cl)](2) has significant antiproliferative activity, although it is less active than cisplatin.

Pd(II) and Pt(II) complexes with aromatic diamines: study of their interaction with DNA.

Pd(II) and Pt(II) new complexes with simple aromatic diamines were synthesised and characterised with the aim of studying their possible antitumour activity. The aromatic diamines chosen were 2,3-diaminotoluene (2,3 dat), 3,4-diaminotoluene (3,4 dat), 4,5-diaminoxylene (4,5 dax) and 2,3-diaminophenol (2,3 dap). The complexes, of formulae cis-[MCl(2)(diamine)], were characterised by elemental analysis, conductivity measurements, 1H, 13C(1H) and 195Pt NMR spectroscopy. The X-ray crystal structure was also resolved for the palladium complexes with 2,3-diaminotoluene and 4,5-diaminoxylene. The DNA adduct formation of the eight new complexes synthesised was followed by circular dichroism and electrophoretic mobility. Atomic force microscopy images of the modifications caused by the complexes on plasmid DNA pBR322 were also obtained. Values of IC50 were also calculated for the four platinum complexes against the cisplatin resistant tumour cell line A2780cisR.

Dimethyl N,N'-oxalamidodiethanoate.

The title compound, dimethyl 2,2'-(oxalyldiimino)diethanoate, C(8)H(12)N(2)O(6), exhibits a network of hydrogen bonds between amide and ester groups. Molecules lie on inversion centres and show a planar conformation for both the oxalamide and ester groups. The glycine residues adopt a conformation close to the polyglycine II structure.

Structural analysis and magnetic properties of the 1D and 3D compounds [Mn(dca)2nbipym] (M = Mn, Cu; dca = dicyanamide; bipym = bipyrimidine; n = 1,2).

Compounds [Mn(dca)2bipym] (1), [Cu2(dca)4bipym] (2), and [Mn2(dca)4bipym] (3) have been synthesized and structural (2, 3) and magnetically characterized. Compound 1 is isomorphous with [Mn(dca)2bipy]. Compound 2 crystallizes in the monoclinic P2(1)/c space group, Z = 4, with a = 7.5609(9), b = 11.477(42), and c = 11.792(2) A and beta = 106.565(6) degrees. Compound 3 crystallizes in the monoclinic system, space group P2(1)/n, with a = 7.396(3) A, b = 11.498(7) A, and c = 12.349(9) A and beta = 106.61(5) degrees. While compound 1 is one-dimensional, with the manganese(II) ions bridged by double mu1,5-dicyanamide ligands, the structural arrangement in compounds 2 and 3 is three-dimensional based on ladder-like moieties. These units, whose steps are bipym groups, extend through mu1,5-dca bridges and are connected to another four on the plane perpendicular to the extension of the ladders to form the 3D arrangement. Magnetic susceptibility measurements show antiferromagnetic couplings in all cases, increasing for 1, 3, and 2, respectively.

Synthesis, characterization, and magnetic properties of self-assembled compounds based on discrete homotrinuclear complexes of Cu(II).

Three new supramolecular entities of Cu(II) were synthesized and characterized: [(Cu(H(2)O)(tmen))(2)(mu-Cu(H(2)O)(opba))](2)[(ClO(4))(2)](2).2H(2)O (1), [(Cu(H(2)O)(tmen))(2) (mu-Cu(H(2)O) (Me(2)pba))](2)[(ClO(4))(2)](2) (2), and [(Cu(H(2)O)(tmen))(Cu(tmen))(mu-Cu(OHpba))](n)() ((ClO(4))(2))(n)().nH(2)O (3), where opba = o-phenylenbis(oxamato), Me(2)pba = 2,2-dimethyl-1,3-propylenbis(oxamato), OHpba = 2-hydroxy-1,3-propylenbis(oxamato), and tmen = N,N,N'N'-tetramethylethylenediamine. The crystal structures of 1, 2, and 3 were solved. Complex 1 crystallizes in the monoclinic system, space group C2/c with a = 20.572(4) A, b = 17.279(6) A, c = 22.023(19) A, beta = 103.13(4) degrees, and Z = 8. Complex 2 crystallizes in the monoclinic system, space group P2(1)/c, with a = 16.7555(7) A, b = 13.5173(5) A, c = 17.1240(7) A, beta = 104.9840(10) degrees, and Z = 4. Complex 3 crystallizes in the orthorhombic system, space group Pca2(1) with a = 21.2859(4) A, b = 12.8286(10) A, c = 12.6456(2) A, and Z = 4. The three complexes are very similar in structure: a trinuclear Cu(II) complex with the two terminal Cu(II) ions blocked by N,N,N',N'-tetramethylethylenediamine, but with a different environment in the Cu(II) central ion. In the case of complex 1, two of these trinuclear entities are packed with a short distance between the central Cu(II) ions of two separate entities forming a hexanuclear-type compound. In the case of 2, two of these trinuclear entities are linked by a hydrogen bond between a water molecule of one terminal Cu(II) and one oxygen atom of the oxamato ligand of the neighboring entity, also forming a hexanuclear complex. In the case of complex 3, the intermolecular linkages give a one-dimensional system where the OH groups of the OHpba entities are linked to the terminal Cu(II) of the neighboring entities. The magnetic properties of the three complexes were studied by susceptibility measurements vs temperature. For complex 1, an intramolecular J value of -312.1 cm(-)(1) and a contact dipolar interaction of -0.44K were found. For complex 2 and 3 the fit was made by the irreducible tensor operator formalism (ITO). The values obtained were as follows: J(1) = -333.9 cm(-)(1) and J(2) = 0.67 cm(-)(1) for 2 and J(1) = -335.9 cm(-)(1) and J(2) = 3.5 cm(-)(1) for 3.

Synthesis, structure, and magnetic properties of three new one-dimensional nickel(II) complexes: new magnetic model for the first one-dimensional S = 1 complex with alternating ferro-ferromagnetic coupling.

Three new one-dimensional nickel(II) complexes with the formulas trans-[Ni(N-Eten)2(mu1.3-N3)]n(ClO4)n (1), trans-[Ni(N-Eten)2(mu1.3-N3)]n(PF6)n (2), and cis-[Ni(N-Eten)(mu1.1-N3)2]n (3) (N-Eten = N-Ethylethylenediamine) were synthesized and characterized. Complex 1 has the P2(1)/c space group and consists of a structurally and magnetically alternating one-dimensional antiferromagnetic system with end-to-end azido bridges. Compound 2 has the P1 space group and has alternate units in its structure but consists of a magnetically uniform one-dimensional antiferromagnetic system with end-to-end azido bridges. Complex 3 has the I2/a space group and may be described as a structurally and magnetically alternating one-dimensional ferromagnetic system with double azido bridged ligands in an end-on coordination mode. The chi(M)T versus T plots for compound 3 suggest an intramolecular ferromagnetic interaction between adjacent NiII ions and metamagnetism at low temperature (below 10 K). The magnetization measurements versus applied field confirm this metamagnetic ordering. In order to describe the magnetic data of this compound we developed a general formula for the magnetic susceptibility of the isotropic ferro-ferromagnetic S = 1 Heisenberg chain in terms of the alternation parameter alpha (= J2/J1); this assumed a variation of chi(M)T versus the length N.

Enantioselective addition of a chiral thiazolidinethione-derived titanium enolate to acetals.

[reaction: see text] High stereoselectivities (up to 98% de) have been achieved for the Lewis acid-mediated cross-coupling reaction of dimethyl acetals to a chiral 1,3-thiazolidine-2-thione-derived titanium enolate. The reaction affords enantiopure anti alpha-methyl-beta-alkoxy carbonyl compounds in a wide range of acetals.

Reactivity in polynuclear transition metal chemistry as a means to obtain high-spin molecules: substitution of mu 4-OH- by eta 1,mu 4-N3- increases nine times the ground-state S value of a nonanuclear nickel(II) cage.

The reaction of di-2-pyridyl ketone, (2-py)2CO, with Ni(O2CMe)(2).4H2O yields the cage [Ni9(OH)2(O2CMe)8((2-py)2CO2)4], which reacts further with N3- ions to give the structurally similar cluster [Ni9(N3)2(O2CMe)8((2-py)2CO2)4] containing extremely rare eta 1,mu 4-N3- groups; magnetic studies reveal that the spin ground state of the latter is nine times the ground state of the former.

A convenient strategy for the synthesis of 4,5-bis(o-haloaryl)isoxazoles

A series of new 1,2-bis(o-haloaryl)ethanones is efficiently prepared and applied to the synthesis of 4,5-bis(o-haloaryl)isoxazoles. Isolation of intermediate hydroxyisoxazolines, which are structurally examined, provides a definitive proof for a heterocyclization mechanism based on an amine exchange process. The isolation and X-ray crystallographic studies of significant side products such as benzamides and triarylpropionitriles are also described.

X-Ray structure of cytotoxic trans-[PtCl(2)(dimethylamine)(isopropylamine)]: interstrand cross-link efficiency, DNA sequence specificity, and inhibition of the B-Z transition.

We report here the X-ray structure of cytotoxic trans-¿PtCl(2)(dimethylamine)(isopropylamine). This trans-platinum compound crystallizes in the monoclinic system, with Z = 8, in the spatial group C2/c with unit cell parameters a = 19.862(17) A, b = 6. 581(3) A, c = 18.563(3) A, alpha = 90 degrees, beta = 119.16(3) degrees, gamma = 90 degrees, V = 2119(2) A(3), rho = 2.321 Mg/m(3), R = 0.0505, and R(w) = 0.1166 on the basis of 2339 independent reflections. To our knowledge this is the first report of the crystal structure of a biologically active trans-platinum compound containing different aliphatic amines. The DNA binding mode of trans-¿PtCl(2)(dimethylamine)(isopropylamine) may be a consequence of the spatial disposition of the dimethylamine and isopropylamine ligands around the trans-Pt(II) center. We have found that trans-¿PtCl(2)(dimethylamine)(isopropylamine) readily forms DNA interstrand cross-links. In addition, the compound shows binding affinity toward alternating purine-pyrimidine sequences and inhibits the B-Z transition. These particular DNA binding properties might be related to the capacity of trans-¿PtCl(2)(dimethylamine)(isopropylamine) for inducing some selective killing in a H-ras overexpresssing cell line.

Synthesis, structure, and magnetic properties of two new ferromagnetic/antiferromagnetic one-dimensional nickel(II) complexes. Magnetostructural correlations.

Two new one-dimensional nickel(II) complexes were synthesized and characterized: [Ni(N,N-dimethylethylenediamine)(N3)2] (1) and [Ni(2-aminoethylpyridine)(N3)2] (2). The crystal structures of 1 and 2 were solved. Complex 1 crystallizes in the monoclinic system, space group P2(1)/n with a = 10.569(2) A, b = 7.331(4) A, c = 12.9072(8) A, beta = 111.324(10) degrees, and Z = 4. Complex 2 crystallizes in the monoclinic system, space group P2(1)/c with a = 12.299(5) A, b = 14.307(2) A, c = 12.604(3), beta = 106.72(2) degrees, and Z = 4. The two complexes are similar and may be described as one-dimensional systems with double-azido-bridged ligands in end-to-end and end-on coordination alternatively. The end-on moiety is almost identical for 1 and 2, but the end-to-end moiety is different in each structure: for 1 this part is almost planar but for 2 is nonplanar. In both cases the Ni atoms are situated in similar distorted octahedral environments. The magnetic properties of the two compounds were studied by susceptibility measurements vs temperature. The chi M vs T plots for 1 and 2 show a global antiferromagnetic behavior with a maximum near room temperature for 1 and at very low temperature for 2. J values for 1 and 2 were deduced from the spin Hamiltonian -sigma(J1SiSi+1 + J2Si+1Si+2). The computational method was based on the numerical solution for finite systems of increasing size. J values for 1 were J1 = -187 cm-1 and J2 = +77 cm-1 and for 2 J1 = -28 cm-1 and J2 = +73 cm-1. The positive values correspond to end-on azido ligands and the negative values to end-to-end azido ligands. Since the geometries of the [Ni(N3)]2 moieties involving the end-on azido ligands are almost the same in the two structures, the ferromagnetic coupling is nearly identical in the two compounds, while the significantly different antiferromagnetic couplings reflect the near planarity of the end-to-end Ni2(N3)2 fragment in 1 and its twisted geometry in 2.

Structural and cytotoxic study of new Pt(II) and Pd(II) complexes with the bi-heterocyclic ligand mepirizole.

Pd(II) and Pt(II) complexes of formulae [MLCl2], where L = mepirizole, were synthesized and characterized. Two complexes were obtained and studied by different techniques: IR, 1H and 13C NMR and XPS spectroscopies and mass spectrometry (electrospray). The crystal structure of the complex cis-dichloro-4-methoxy-2-(5-methoxy-3-methyl- pyrazol-1-yl)-6-methyl-pyrimidinepalladium(II), [Pd(mep)Cl2], was studied by crystal X-ray diffraction. It consists of discrete molecules with planar geometry. Pd(II) ions are four-coordinated by two mepirizole nitrogen atoms (N1 from the pyrazole ring and N4 from the pyrimidine ring) and two chlorine atoms. The geometry of the PdN2Cl2 chromophore is a distortion of the square-planar coordination. Data from powder pattern X-ray diffraction of cis-dichloro-4-methoxy-2-(5-methoxy-3-methyl-pyrazol-1-yl)-6-methyl- pyrimidineplatinum(II), [Pt(mep)Cl2], demonstrated that the two complexes are isostructural. The cytotoxic activity of both Pd and Pt complexes was checked for six different tumor cell lines and was lower than that of cisplatin. The Pt bound to DNA was also checked and only a low percentage is able to cross the cell membrane.

Pd(II) and Pt(II) Complexes of Schiff Thiobases Derived From 2-Carbonylpyridine.

Pd(ll) and Pt(ll) complexes of three series of Schiff thiobases derived from 2- carbonylpyridine have been synthesized and characterized. The crystal structure of the Pt(ll) derivative of methyl-3-(2-pyridylmethylene)hydrazinecarbodithioate (HFp) was resolved. The ligand coordinates the platinum ion in tridentate fashion by heterocycle and imine nitrogen and thiocarbonyl sulfur. The fourth ligand is a chloride ion. The structure of the complexes is suitable for the formation of monofunctional adducts with DNA. Studies on the interaction of the complexes with Calf thymus DNA by CD reveal modifications in the B form of lineal DNA. Interaction with plasmid DNA was also confirmed in the images obtained by atomic force microscopy.

Crystal structure and molecular conformation of the cyclic hexapeptide cyclo-(Gly-Aib-Gly)2.

We have synthesized and crystallized the cyclic peptide (Gly-Aib-Gly)2. Its structure has been determined by conventional X-ray diffraction methods. In the crystal it adopts a conformation with one beta-turn (type I) and its mirror image at the other side of the ring. All conformational angles are similar to those reported for these amino acids residues. In particular the Aib residue has a conformation intermediate between alpha- and 3(10)-helical conformations. The ring is an adequate model for the beta-turn conformation. A molecule of formic acid is found in the crystal which shows a very short hydrogen bond with one of the glycine carbonyl groups.

Crystal structures and spectroscopic studies of ternary compounds of Ni(II) with ethylenediamine and 5'GMP and 5'IMP.

Two metal complexes [Ni(en)5'GMPH)2(H2O)2] (en).6.5H2O and [Ni(en)(5'IMPH)2(H2O)2].13H2O have been synthesized in the form of suitable crystals for x-ray crystallography (en = ethylenediamine, 5'GMP = guanosine 5'-monophosphate, 5'IMP = inosine 5'-monophosphate). The 5'GMP complex crystallizes in a monoclinic space group P21 (Z = 4) with a = 12.317(2), b = 28.417(4), c = 12.290(2)A, beta (deg) = 89.59(2). The 5'IMP complex is tetragonal, space group P4122 (Z = 4), with a = 12.119(3), b = 12.119(3), c = 28.560(4)A, beta (deg) = 90.0. The crystal structures of both complexes were refined from diffractometer data to conventional R values of 0.073 for the 5'GMP compound (5,284 observed reflections, 1,322 variables) and 0.030 for the 5'-IMP compound (1,529 observed reflections, 296 variables). In both structures, the Ni(II) is surrounded by two water molecules, one chelate ethylenediamine, and two nucleotide molecules. The synthesis was carried out from Ni(en)2Cl2.0.5H2O and the nucleotide in water medium. The dimer structure of the initial complex is broken, and one ethylenediamine is substituted by two molecules of the nucleotide with the N(7) of the purine ring in cis-position. Differences between both structures are largely due to retention in the structure or loss of the en molecule substituted and to the intermolecular hydrogen bonds of the en molecule coordinated. A third complex of composition [Ni(en)(5'IMPH)2(H2O)2] (en).6H2O similar to the 5'GMP complex has been obtained in the form of blue crystals, but unfortunately its crystal structure failed to be refined. This complex is isostructural with the monoclinic one.

Structures of chloro(glycinato)(1,10-phenanthroline)copper(II) monohydrate (I) and aqua(1,10-phenanthroline)(L-phenylalaninato)copper(II) nitrate monohydrate (II).

(I) [CuCl(C2H4NO2)(C12H8N2)].H2O, Mr = 371.28, orthorhombic, P2(1)2(1)2(1), a = 6.795 (3), b = 12.496 (4), c = 17.273 (5) A, V = 1467 (1) A3, Dx = 1.680 Mg m-3, Z = 4, F(000) = 756, lambda(Mo K alpha) = 0.71069 A, mu(Mo K alpha) = 1.742mm-1. Room temperature. Final R = 0.046 for 1302 unique observed reflections. (II) [Cu(C9H10NO2)(C12H8N2)(H2O)]NO3.-H2O, Mr = 505.98, monoclinic, P2(1), a = 5.782 (2), b = 20.700 (6), c = 9.355 (3) A, beta = 97.58 (2)degrees, V = 1110 (1) A3, Dx = 1.514 Mg m-3, Z = 2, F(000) = 522, lambda(Mo K alpha) = 0.71069 A, mu(Mo K alpha) = 1.076 mm-1. Room temperature. Final R = 0.069 for 1929 unique observed reflections. The Cu ion displays distorted square-pyramidal coordination in both (I) and (II), with the chlorine atom (I) or the water molecule (II) in the apical position. The Cu-N bond lengths alter according to the electronegative character of the trans atom. The conformations of the five-membered chelate rings appear to depend on H bonding and van der Waals interactions.

Crystal and molecular structure of the sodium salt of the dinucleotide duplex d(CpG).

The crystal and molecular structure of the sodium salt of deoxycytidylyl-(3H-5H)-deoxyguanosine has been determined from X-ray diffraction data. The crystal, obtained from an aqueous gamma-butyrolactone solution at pH = 5.3 are orthorhombic, P212121, a = 10.640(2), b = 11.184(2) and c = 44.618(4)A. The structure was refined to an R = 0.041. The d(CpG) structure is similar to the ammonium salt solved by Cruse et al.(1). Both structures form a parallel self base paired mini-double helix. In d(CpG).Na+ one of the two paired cytosines is protonated on N(3). The cytosines form 3 hydrogen bonds while the guanines form only 2. The Na+ ion is coordinated with five groups: two water molecules, O(6) of guanine A, N(7) of guanine B and 0(5') of cytosine B, forming a square pyramid. The hydration shell around the mini-helix is analysed and compared with that of the ammonium salt, d(CpG).Na+ is the second d(CpG) oligonucleotide found with a self base pairing arrangement despite of the fact that the crystallization conditions and counterion were different in both cases. The hypothesis that self base pairing is not only a crystallization artifact but may play a role under physiological conditions as a source of transversion mutations is discussed.